Abstract
The vast majority of clinically used antitumour drugs are either synthetic or natural product based organic compounds. The platinum antitumour agents are unique in that they are coordination complexes. The parent compound of this class, cis-diamminedichloroplatinum(II) (cisplatin), contributes to the curative treatment of testicular teratoma and has significant activity against ovarian, head and neck, bladder, cervical and lung cancers. The compound is also highly toxic with the list of side effects including renal damage, severe nausea and vomiting, myelosuppression, ototoxicity and neurotoxicity. Since the antitumour properties of cisplatin were reported by Rosenberg and coworkers in 1969, well over 1000 platinum analogues have been tested for antitumour activity1,2. The goal of this work has been to find analogues with reduced toxicity and/or wider spectrum of activity. Active cisplatin analogues are generally neutral platinum complexes containing two ammine (NH3) or amine ligands in a cis configuration in concert with two (for Pt(II) analogues) or four (for Pt(IV) compounds) relatively labile halide or oxygen ligands3. Complexes with amine groups in a trans configuration are invariably inactive4. Structure-activity relationships (in animal tumour models) and the clinical aspects of platinum drugs have been reviewed2–6.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
B. Rosenberg, L. Van Camp. J.E. Trosko and V.H. Mansour, Nature 222 (1969) 385.
J.C. Dabrowiak and W.T. Bradner, Prog. Med. Chem. 24 (1987) 129.
A. Pasini and F. Zunino, Angew. Chem. Int. Ed. Engl. 26 (1987) 615.
B. Rosenberg, Cancer 55 (1985) 2303.
W.C. Rose, J.E. Shurig, J.B. Huftalen and W.T. Bradner, Cancer Treat. Rep. 66 (1982) 135.
C.F.J. Barnard, M.J. Cleare and P.C. Hydes, Chem. Brit. 22 (1986) 1001.
A. Werner, Z. Anorg. Chem. 3 (1893) 267.
G.B. Kauffman and D.O. Cowan, Inorg. Synth. 1 (1963) 239.
V.V. Lebedinskii and V.A. Golovnya, Izv. Sektora Platiny Drug Blagorod. Metal., Inst. Obshch. Neorg. Khim. Akad. Nauk. S.S.S.R 20 (1947) 95.
J.W. Reishus and D.S. Martin Jr., J. Am. Chem. Soc. 83 (1961) 2457.
S.C. Dhara, Indian J. Chem. 8 (1970) 193.
G. Raudaschl, B. Lippert, J.D. Hoeschele, H.E. Howard-Lock, C.J.L. Lock and P. Pilon, Inorg. Chim. Acta 106 (1985) 141.
G.H.W. Milburn and M.R. Truter, J. Chem. Soc. (A) (1966) 1609.
K. Nakamoto, P.J. McCarthy, J. Fujita, R.A. Condrate and G.T. Behnke, Inorg. Chem. 4 (1965) 36.
J.R. Perumareddi and A.W. Adamson, J. Phys. Chem. 72 (1968) 414.
F. Macdonald and P.J. Sadler, in Biochemical Mechanisms of Platinum Antitumour Drugs, eds. D.C.H. McBrien and T.F. Slater, IRL Press, Oxford (1986) p. 199.
N.S. Kurnakov, J. Russ. Phys. Chem. Soc. 25 (1893) 565.
F. Basolo, M. Lederer, L. Ossicini and K.H. Stephen, J. Chromatogr. 10 (1963) 262.
F. Aprile and D.S. Martin Jr., Inorg. Chem. 1 (1962) 551.
C. Barnard, Unpublished results.
K.W. Lee and D.S. Martin Jr, Inorg. Chim. Acta 17 (1976) 105.
M.C. Lim and R.B. Martin, J. Inorg. Nucl. Chem. 38 (1976) 1911.
T.G. Appleton, R.D. Berry, C.A. Davis, J.R. Hall and H.A. Kimlin, Inorg. Chem. 23 (1984) 3514.
C.J.L. Lock, in Inorganic Chemistry in Biology and Medicine, ed. A.E. Martell, ACS Symp. Ser. Vol. 140 (1980) p. 209.
B. de Castro, T.J. Kistenmacher and L.G. Marzilli, Agents Actions Suppl. 8 (1981) 435.
S.E. Sherman and S.J. Lippard, Chem. Rev. 87 (1987) 1153.
C.A. McAulliffe and S.H. Murray, Inorg. Chim. Acta Rev. 6 (1972) 103.
R.F. Borch and M.E. Pleasants, Proc. Natl. Acad. Sci. USA 16 (1979) 6611.
V.M. Richon. N. Schulte and A. Eastman, Cancer Res. 41 (1987) 2056.
B. Odenheimer and W. Wolf, Inorg. Chim. Acta 66 (1982) L41.
P.T. Daley-Yates and D.C.H. McBrien, Biochem. Pharmacol. 33 (1984) 3063.
J.L. Aull, R.L. Allen, A.R. Bapat, H.H. Daron, M.E. Friedman and J.F. Wilson, Biochem. Biophys. Acta 571 (1979) 352.
P.T. Daley-Yates and D.C.H. McBrien, Chem. Biol. Interact. 40 (1982) 325.
S.L. Gonias and S.V. Pizzo, J. Biol. Chem. 258 (1983) 5764.
S.V. Pizzo, M.W. Swaim, P.A. Roche and S.L. Gonias, J. Inorg. Biochem. 33 (1988) 67.
M.E. Howe-Grant and S.J. Lippard, in Metal Ions in Biological Systems, ed. H. Sigel, Marcel Dekker, New York (1980) p. 63.
A.J. Zelazowski, J.S. Garvery and J.D. Hoeschele, Arch. Biochem. Biophys. 229 (1984) 246.
P.C. Dedon, R. Qazi and R.F. Borch, in Biochemical Mechanisms of Platinum Antitumour Drugs, eds. D.C.H. McBrien and T.F. Slater, IRL Press, Oxford (1986) p. 199.
D.L. Bodenner, P.C. Dedon, P.C. Keng and R.C. Borch, Cancer Res. 46 (1986) 2745.
H. Iwabuchi, H. Nagashima and K. Nakamura, Bunseki Kagaku 37 (1988) 88.
N. Jain, T.S. Srivastava, K. Satymoorthy and M.P. Chitnis, J. Inorg. Biochem. 33 (1988) 1.
W.I. Sundquist, K.J. Ahmed, L.S. Hollis and S.J. Lippard, Inorg. Chem. 26 (1987) 1524.
V. Savdek, H. Pivcova, D. Noskova and J. Drobnik, J. Inorg. Biochem. 24 (1985) 13.
T.S. Elleman, J.W. Reishus and D.S. Martin Jr., J. Am. Chem. Soc. 80 (1958) 536.
M.J. Abrams, C.M. Giandomenico, J.F. Vollano and D.A. Schwartz, Inorg. Chim. Acta 131 (1987) 3.
P.D. Braddock, T.A. Connors, M. Jones, A.R. Khokhar, D.H. Melzack and M.L. Tobe, Chem.-Biol. Interact. 11 (1975) 145.
K.R. Harrap, M. Jones, C.R. Wilkinson, H. McD. Clink, S. Sparrow, B.C.V. Mitchley, S. Clarke and A. Veasey, in Cisplatin: Current Status and New Developments, eds. A.W. Prestayko, S.T. Crooke and S.K. Carter, Academic Press, New York (1980) p. 193.
M.J. Cleare, J.D. Hoeschele, B. Rosenberg and L. Van Camp, U.S. Patent. 4,140,707, 1979.
R.C. Harrison, C.A. McAuliffe and A.M. Zaki, Inorg. Chim. Acta 46 (1980) L15.
A. Pasini and C. Caldirola, Inorg. Chim Acta 151 (1988) 19.
S. Neidle. I.M. Ismail and P.J. Sadler, J. Inorg. Biochem. 13 (1980) 205.
Y.W. Cheung. J.C. Cradock. B.R. Vishnuvajjala and K.P. Flora, Am. J. Hosp. Pharm. 44 (1987) 124.
L. Canovese, L. Cattalini, G. Chessa and M.L. Tobe. J. Chem. Soc., Dalton Trans. (1988) 2135.
J.J. Roberts, R.J. Knox, F. Friedlos and D.A. Lydall, in Biochemical Mechanisms of Platinum Antitumor Drugs, eds. D.C.H. McBrien and T.F. Slater, IRL Press, Oxford (1986) p. 29.
S.J. Harland, D.R. Newell, Z.H. Siddik, R. Chadwick, A.H. Calvert and K.R. Harrap, Cancer Res. 44 (1984) 1693.
S. Mong, C.H. Huang, A.W. Prestayko and S.T. Crooke, Cancer Res. 40 (1980) 3318.
M.J. Cleare and J.D. Hoeschele, Bioinorg. Chem. 2 (1973) 187.
D.R. Alston, T.H. Lilley and J.F. Fraser, J. Chem. Soc. Chem. Commun. 22 (1985) 1600.
D.R. Alston, A.M.Z. Slawin, J.F. Fraser and D.J. Williams, J. Chem. Soc. Chem. Commun. 22 (1985) 1602.
G. Hortobagyi, F. Holmes, D. Frye, V. Hug and G. Fraschini, Proc. Am. Assoc. Cancer Res. 28 (1987) 198.
C.F.J. Barnard, P.C. Hydes, W.P. Griffiths and O.S. Mills, J. Chem. Res. (S) (1983) 302.
E. Smith and A.H.W. Nias, Br. J. Radiol. 59 (1986) 189.
J.W. Cowens, F.A. Stevie, J.L. Alderfer, G.E. Hansen, L. Pendyala and P.J. Creaven, Int. J. Mass Spectrom. Ion Phys. 48 (1983) 177.
J.F. Vollano, E.E. Blatter and J.C. Dabrowiak, J. Am. Chem. Soc. 106 (1984) 2732.
E.E. Blatter, J.F. Vollano, B.S. Krishnan and J.C. Dabrowiak, Biochemistry 23 (1984) 4817.
L. Pendyala, L. Cowens and S. Madajewicz, in Platinum Coordination Complexes in Chemotherapy, eds. M.P. Hacker. E.B. Douple and I.R. Krakoff, Martinus Nijhoff, Boston, MA (1984) p. 114.
J.L. Van der Veer, A.R. Peters and J. Reedijk, J. Inorg. Biochem. 26 (1986) 137.
J.H. Burchenal, K. Kalaher, K. Dew, L. Lokys and G. Gale, Biochimie 60 (1978) 961.
A. Eastman and S. Illenye, Cancer Treat. Rep. 68 (1984) 1189.
J.F. Vollano, S. Al-Baker, J.C. Dabrowiak and J.E. Schurig, J. Med. Chem. 30, (1987) 716.
Y. Kidani, K. Inagaki, M. Iigo, A. Hoshi and K. Kuretani, J. Med. Chem. 21 (1978) 1315.
R. Saito and Y. Kidani, Chem. Lett. (1976) 123.
P. Schwartz, S.J. Meischen, G.R. Gale, L.M. Atkins, A.B. Smith and E.M. Walker Jr., Cancer Treat. Rep. 61 (1977) 1519.
D.P. Kelsen, H. Scher, N. Alcock, B. Leyland-Jones, A. Donner, L. Williams, G. Greene, J.H. Burchenal, C. Tan, F.S. Philips and C.W. Young, Cancer Res. 42 (1982) 4831.
P.J. Andrulis Jr., J. Biswas, A. Troy and P. Andrulis III, in Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy, ed. M. Nicolini, Martinus Nijhoff, Boston, MA (1988) p. 450.
M.A. Bruck, R. Bav, M. Noji, K. Inagaki and Y. Kidani, Inorg. Chim. Acta 92 (1984) 279.
A.R. Khokhar, G. Lumetta and S.L. Doran, Inorg. Chim. Acta 151 (1988) 87.
Y. Kidani, in Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy, ed. M. Nicolini, Martinus Nijhoff, Boston, MA (1988) p. 555.
W.K. Anderson, D.A. Quagliato, R.D. Haugwitz, V.L. Narayanan and M.K. Wolpert-DeFilippes, Cancer Treat. Rep. 70 (1986) 997.
B.R. Vishnuvajjala, U.S. Patent Applic. 780,932, 1985.
W.K. Anderson and D.A. Quagliato, U.S. Patent. 4,550,187, 1985.
A. Eastman, Biochem. Pharmacol. 36 (1987) 4177.
L.S. Hollis, A.R. Amundsen and E.W. Stern, J. Am. Chem. Soc. 107 (1985) 274.
R. Perez-Soler, A.R. Khokhar, M.P. Hacker and G. Lopez-Berestein, Cancer Res. 46 (1986) 6269.
T.H. Corbett, F.A. Valeriote and L.H. Baker, Invest. New Drugs 5 (1987) 3.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Blackie & Son Ltd
About this chapter
Cite this chapter
Abrams, M.J. (1990). The chemistry of platinum antitumour agents. In: Wilman, D.E.V. (eds) The Chemistry of Antitumour Agents. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-0397-5_12
Download citation
DOI: https://doi.org/10.1007/978-94-009-0397-5_12
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6665-5
Online ISBN: 978-94-009-0397-5
eBook Packages: Springer Book Archive